Last updated on April 2019

Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRC


Brief description of study

This study determine the maximal tolerate dose

Detailed Study Description

This study determine the maximal tolerate dose for the patient treated by intraperitoneal chemotherapy in neoadjuvant treatment of peritoneal carcinomatosis of colorectal origin

Clinical Study Identifier: NCT03253133

Find a site near you

Start Over